Treatment strategies for autoimmune hepatitis

American Journal of Gastroenterology

Volumn 101, Issue SUPPL. 3, 2006, Pages s630-s632

  Heathcote, Jenny ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPHOSPHONIC ACID; CALCIUM; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; PHOSPHONIC ACID DERIVATIVE; PREDNISONE; VITAMIN D;

AUTOIMMUNE HEPATITIS; CONFERENCE PAPER; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MONOTHERAPY; OSTEOPOROSIS; PATIENT EDUCATION; PREGNANCY; PRIORITY JOURNAL; RELAPSE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

EID: 33845408502     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00979.x     Document Type: Conference Paper

References (20)

1. Abdalian R, Dhar P, Jhaveri K, et al. Prevalence of PSC in adult patients with a primary diagnosis of AIH: Evaluating the role of routine magnetic resonance imaging. Hepatol 2005;42(suppl 1): 208A.
2. Alvarez F, Berg FB, Bianchi L, et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;321:929-38.
3. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;158:159-85.
4. Soloway RD, Summerskill WHJ, Archie H, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology 1972;820-33.
5. Murray-Lyon IM. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973;735-7.
6. Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 1988;95:448-53.
7. Kanzler S, Gerken G, Lohr H, et al. Duration of immunosuppressive therapy in autoimmune hepatitis [Letter to the Editor]. J Hepatol 2001;34:354-5.
8. Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004;40:646-52.
9. Roberts SK, Therneau T, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996;110:848-57.
10. Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005;42:53-62.
11. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
12. Hegarty JE, Nouri Aria KT, Portmann B, et al. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 1983;3:685-9.
13. Verma S, Gunuwan B, Mendler M, et al. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004;99:1510-6.
14. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-63.
15. Czaja AJ, Mennon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis. Hepatology 2002;35:890-7.
16. Fernandes NF, Redeker AG, Vierling JM, et al. Cyclosporine in therapy in patients with steroid-resistant autoimmune hepatitis. Am J Gastroenterol 1999;94:241-8.
17. Richardson PD, James P, Ryder S. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000;33:371-5.
18. Burak K, Urbanski S, Swain M. Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate. J Hepatol 1998;29:990-3.
19. Ayata G, Gordon FD, Lewis WD, et al. Liver transplantation for autoimmune hepatitis: A long-term pathologic study. Hepatology 2000;32:185-92.
20. Buchel E, Van Steenbergen W, Nevens F, et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002;97:3160-5.